12.01 increases in primary profit from the same period last year. During 2018, the financial statement includes the hemodialysis solution and other medical product manufacturing and trading business from

operations for 2nd Quarter of 2017 decreased to 71.69%, while it was 74.38% for the 2nd Quarter of 2016. These resulted from the efficiency of medicine and medical supplies cost management, introducing an

operations incurred compared to total revenues were 65.8% and 68.6% repectively. This increase stemmed from doctor fee, renumeration, and any other fringe benefits, which resulted from the increase of Medical

, The Company’s strategies such as increasing more specialty cilinics, medical instruments and expanding into new market so as to drive a sustainable growth Cost of Hospital Operations The costs of

increasing number of out patients. Therefore, the hospital management is focusing on improving the quality of medical services related to non-communicable diseases such cardiovascular disease, neurologic

Reef:020/1999 Ref : 27/2018 May 14, 2018 Subject : The explanation of operating results for the first quarter of 2018 To : The SET President Vibhavadi Medical Center Plc. would like to disclose the

Reef:020/1999 Ref : 53/2019 November 14, 2019 Subject : The explanation of operating results for the third quarter of 2019 To : The SET President Vibhavadi Medical Center Plc. would like to disclose

Reef:020/1999 Ref : 11/2018 February 26, 2018 Subject : The explanation of operating results for the year of 2017 To : The SET President Vibhavadi Medical Center Plc. hereby submits a copy of its

Reef:020/1999 Ref : 73/2017 November 13, 2017 Subject : The explanation of operating results for the Third quarter of 2017 To : The SET President Vibhavadi Medical Center Pcl. would like to disclose

subsidiaries have the revenues from medical treatment of 947.83 million baht, which is a 7.48 % increase from the previous year. The revenues can from the two hospitals are broken down as follows